BDSX - CIK 0001439725
The table below shows BIODESIX INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $25.57M | $16.60M | $20.73M | $17.60M | $31.41M | $42.22M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $9.50M | $12.67M | $7.45M | $7.64M | $8.04M | $10.13M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $40.91M |
| $33.40M |
| $32.45M |
| $29.62M |
| $44.02M |
| $57.58M |
| Property, plant & equipment | $24.19M | $25.46M | $26.14M | $26.97M | $28.68M | $28.02M |
| Goodwill | $15.03M | $15.03M | $15.03M | $15.03M | $15.03M | $15.03M |
| Total assets | $94.64M | $88.72M | $87.74M | $86.24M | $102.74M | $115.84M |
| Accounts payable | $3.65M | $3.62M | $2.97M | $2.92M | $2.54M | $2.22M |
| Total current liabilities | $14.49M | $18.15M | $15.16M | $13.32M | $12.96M | $17.55M |
| Long-term debt | $50.00M | $50.01M | $50.02M | $40.02M | $40.04M | $40.05M |
| Total liabilities | $85.50M | $90.44M | $86.60M | $75.18M | $74.89M | $79.58M |
| Retained earnings | -$505.56M | -$493.78M | -$485.07M | -$473.60M | -$454.25M | -$443.99M |
| Total equity | $9.13M | -$1.72M | $1.14M | $11.06M | $27.86M | $36.26M |